These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1656016)

  • 1. Pharmacologic profile of (R)-5-[(1-methyl-3-indolyl)carbonyl]-4,5,6,7-tetrahydro-1H- benzimidazole hydrochloride (YM060), a potent and selective 5-hydroxytryptamine3 receptor antagonist, and its enantiomer in the isolated tissue.
    Miyata K; Kamato T; Nishida A; Ito H; Katsuyama Y; Iwai A; Yuki H; Yamano M; Tsutsumi R; Ohta M
    J Pharmacol Exp Ther; 1991 Oct; 259(1):15-21. PubMed ID: 1656016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of YM060, a potent and selective 5-hydroxytryptamine3 receptor antagonist, in rabbit nodose ganglion and N1E-115 neuroblastoma cells.
    Ito H; Hidaka K; Miyata K; Kamato T; Nishida A; Honda K
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1127-32. PubMed ID: 1469624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin (5-HT)3 receptor blocking activities of YM060, a novel 4,5,6,7-tetrahydrobenzimidazole derivative, and its enantiomer in anesthetized rats.
    Miyata K; Kamato T; Yamano M; Nishida A; Ito H; Katsuyama Y; Yuki H; Tsutsumi R; Ohta M; Takeda M
    J Pharmacol Exp Ther; 1991 Nov; 259(2):815-9. PubMed ID: 1941629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of serotonin (5-HT)3-receptor antagonists YM060, YM114 (KAE-393), ondansetron and granisetron on 5-HT4 receptors and gastric emptying in rodents.
    Miyata K; Yamano M; Kamato T; Akuzawa S
    Jpn J Pharmacol; 1995 Nov; 69(3):205-14. PubMed ID: 8699628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on serotonin (5-HT)3-receptor antagonist effects of enantiomers of 4,5,6,7-tetrahydro-1H-benzimidazole derivatives.
    Kamato T; Ito H; Suzuki T; Miyata K; Honda K
    Jpn J Pharmacol; 1995 Mar; 67(3):185-94. PubMed ID: 7630036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of FK1052, a dihydropyridoindole derivative, as a new serotonin 3 and 4 dual receptor antagonist.
    Nagakura Y; Kadowaki M; Tokoro K; Tomoi M; Mori J; Kohsaka M
    J Pharmacol Exp Ther; 1993 May; 265(2):752-8. PubMed ID: 8496821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiemetic effects of YM060, a potent and selective serotonin (5HT)3-receptor antagonist, in ferrets and dogs.
    Kamato T; Miyata K; Ito H; Yuki H; Yamano M; Honda K
    Jpn J Pharmacol; 1991 Nov; 57(3):387-95. PubMed ID: 1813664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of the affinities of the 5-HT3 receptor antagonists, YM060, YM114 (KAE-393), granisetron and ondansetron in rat vagus nerve and cerebral cortex.
    Ito H; Akuzawa S; Tsutsumi R; Kiso T; Kamato T; Nishida A; Yamano M; Miyata K
    Neuropharmacology; 1995 Jun; 34(6):631-7. PubMed ID: 7566499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin (5-HT)3-receptor antagonism of 4,5,6,7-tetrahydrobenzimidazole derivatives against 5-HT-induced bradycardia in anesthetized rats.
    Yamano M; Kamato T; Nishida A; Ito H; Yuki H; Tsutsumi R; Honda K; Miyata K
    Jpn J Pharmacol; 1994 Jul; 65(3):241-8. PubMed ID: 7799524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of inhibitory effects of serotonin (5-HT)3-receptor antagonists, YM060 and YM114 (KAE-393), on the von Bezold-Jarisch reflex induced by 2-Methyl-5-HT, veratridine and electrical stimulation of vagus nerves in anesthetized rats.
    Yamano M; Ito H; Kamato T; Miyata K
    Jpn J Pharmacol; 1995 Dec; 69(4):351-6. PubMed ID: 8786638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of YM060 on 5-HT3 receptor-mediated depolarization in colonic myenteric neurons of the guinea pig.
    Ito H; Tamura K
    Eur J Pharmacol; 1995 Sep; 283(1-3):107-12. PubMed ID: 7498299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the pharmacology of the novel histamine H3 receptor agonist Sch 50971.
    Hey JA; Aslanian R; Bolser DC; Chapman RW; Egan RW; Rizzo CA; Shih NY; Fernandez X; McLeod RL; West R; Kreutner W
    Arzneimittelforschung; 1998 Sep; 48(9):881-8. PubMed ID: 9793613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of the novel histamine H3-receptor antagonist N-(3,5-dichlorophenyl)-N'-[[4-(1H-imidazol-4-ylmethyl)phenyl]-methyl]-urea (SCH 79687).
    McLeod RL; Rizzo CA; West RE; Aslanian R; McCormick K; Bryant M; Hsieh Y; Korfmacher W; Mingo GG; Varty L; Williams SM; Shih NY; Egan RW; Hey JA
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1037-44. PubMed ID: 12649305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro characterization of the adrenoceptor activity of AY-28,925.
    Rimele TJ; Heaslip RJ; Lee DK; Grimes D
    J Pharmacol Exp Ther; 1986 Oct; 239(1):1-8. PubMed ID: 2876089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel 5-hydroxytryptamine (5-HT3) receptor antagonists. IV. Synthesis and pharmacological evaluation of the oxidation products of (-)-(R)-5-[(1-methyl-1H-indol-3-yl)carbonyl] -4,5,6,7-tetrahydro-1H-benzimidazole hydrochloride (YM060: ramosetron).
    Ohta M; Suzuki T; Nagashima S; Tokunaga T; Miyata K; Mase T
    Chem Pharm Bull (Tokyo); 1996 Sep; 44(9):1717-22. PubMed ID: 8855366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the contraction to 5-HT in the canine colon longitudinal muscle.
    Prins NH; Briejer MR; Schuurkes JA
    Br J Pharmacol; 1997 Feb; 120(4):714-20. PubMed ID: 9051313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective 5-hydroxytryptamine3 (5-HT3) receptor blocking activity of KB-R6933, a novel benzimidazole derivative.
    Ozaki A; Fujishima Y; Sukamoto T
    Jpn J Pharmacol; 1999 May; 80(1):25-32. PubMed ID: 10446753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological properties of quinoxaline derivatives as a new class of 5-HT3 receptor antagonists.
    Lasheras B; Berjón A; Montañés R; Roca J; Romero G; Ramírez MJ; Del Río J
    Arzneimittelforschung; 1996 Apr; 46(4):401-6. PubMed ID: 8740088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel 5-hydroxytryptamine (5-HT3) receptor antagonists. III. Pharmacological evaluations and molecular modeling studies of optically active 4,5,6,7-tetrahydro-1H-benzimidazole derivatives.
    Ohta M; Suzuki T; Furuya T; Kurihara H; Tokunaga T; Miyata K; Yanagisawa I
    Chem Pharm Bull (Tokyo); 1996 Sep; 44(9):1707-16. PubMed ID: 8855365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and structure-activity relationships of potent and orally active 5-HT4 receptor antagonists: indazole and benzimidazolone derivatives.
    Schaus JM; Thompson DC; Bloomquist WE; Susemichel AD; Calligaro DO; Cohen ML
    J Med Chem; 1998 May; 41(11):1943-55. PubMed ID: 9599243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.